OZEM Holdings
Roundhill Investments - GLP-1 & Weight Loss ETF
1W: -4.1%
1M: -9.7%
3M: -11.3%
YTD: -12.8%
1Y: +5.3%
$29.93
-0.26 (-0.85%)
Weekly Expected Move ±2.9%
$28
$29
$30
$31
$32
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Dividends
Weather
ETF-Level Metrics
AUM$38M
Holdings26
Top 10 Wt66.2%
Beta0.43
% Profitable48%
Coverage92%
Portfolio Valuation
P/E18.7
P/B4.5
P/S4.8
EV/EBITDA13.7
P/FCF23.5
PEG0.82
Profitability & Returns
Gross Margin71.2%
Net Margin25.9%
ROE25.5%
ROA15.8%
ROIC27.1%
Div Yield2.12%
Leverage & Liquidity
Debt/Equity0.24
Debt/Assets0.15
Net Debt/EBITDA-0.3x
Interest Cov28.8x
Current Ratio2.10
Quick Ratio1.61
Growth (YoY)
Revenue+14.3%
Net Income+13.6%
EPS+20.5%
FCF+39.4%
EBITDA+14.3%
Rev CAGR 3Y+28.5%
Quality Scores
Piotroski F5.8
Altman Z11.43
IS Quality75.7
IS Overall64.1
IS Value46.2
Median P/E11.3
Sector Breakdown
2 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 24 | 99.9% | 10.5 |
| Other | 3 | 0.1% | — |
Smart Money Overlap
2 holdings with signals
Showing 27 of 27 holdings
· Page 1 of 1
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | Eli Lilly & Co | LLY | 12.67% | $7.3M | 6,323 | 38.2 | $1.1T | Healthcare |
| 2 | Novo Nordisk A/S | NVO | 11.07% | $6.4M | 168,720 | 9.5 | $165.7B | Healthcare |
| 3 | Pfizer Inc | PFE | 7.68% | $4.4M | 155,443 | 36.7 | $158.4B | Healthcare |
| 4 | CSPC Pharmaceutical Group Ltd | 1093.HK | 6.51% | $3.8M | 2,930,000 | 13.0 | $113.3B | Healthcare |
| 5 | Viking Therapeutics Inc | VKTX | 5.46% | $3.2M | 96,697 | -6.4 | $3.5B | Healthcare |
| 6 | Kailera Therapeutics Inc | KLRA | 5.16% | $3.0M | 260,799 | — | $1.3B | Healthcare |
| 7 | Chugai Pharmaceutical Co Ltd | 4519.T | 4.63% | $2.7M | 67,500 | 21.1 | $9.9T | Healthcare |
| 8 | Ascletis Pharma Inc | 1672.HK | 4.38% | $2.5M | 2,375,000 | -11.7 | $8.5B | Healthcare |
| 9 | Amgen Inc | AMGN | 4.36% | $2.5M | 5,971 | 24.8 | $217.5B | Healthcare |
| 10 | Hanmi Pharm Co Ltd | 128940.KS | 4.32% | $2.5M | 6,768 | 27.3 | $6.4T | Healthcare |
| 11 | Zealand Pharma A/S | ZEAL.CO | 3.93% | $2.3M | 55,165 | 6.8 | $18.2B | Healthcare |
| 12 | AstraZeneca PLC | AZN | 3.78% | $2.2M | 13,509 | 23.4 | $243.3B | Healthcare |
| 13 | Roche Holding AG | ROP.SW | 3.10% | $1.8M | 4,286 | 22.5 | $275.2B | Healthcare |
| 14 | Jiangsu Hengrui Pharmaceuticals Co Ltd | 1276.HK | 2.90% | $1.7M | 261,600 | — | $329.6B | Healthcare |
| 15 | United Laboratories International Holdings Ltd/The | 3933.HK | 2.89% | $1.7M | 1,644,000 | 23.4 | $15.0B | Healthcare |
| 16 | Hansoh Pharmaceutical Group Co Ltd | 3692.HK | 2.84% | $1.6M | 364,000 | 26.5 | $207.0B | Healthcare |
| 17 | Innovent Biologics Inc | 1801.HK | 2.47% | $1.4M | 114,000 | 116.0 | $167.6B | Healthcare |
| 18 | Structure Therapeutics Inc | GPCR | 2.46% | $1.4M | 45,508 | -9.1 | $1.6B | Healthcare |
| 19 | Gubra A/S | GUBRA.CO | 2.31% | $1.3M | 27,392 | -26.8 | $4.9B | Healthcare |
| 20 | MBX Biosciences Inc | MBX | 2.08% | $1.2M | 20,530 | -24.4 | $2.8B | Healthcare |
| 21 | Gilead Sciences Inc | GILD | 1.83% | $1.1M | 7,109 | -55.7 | $179.5B | Healthcare |
| 22 | Rhythm Pharmaceuticals Inc | RYTM | 1.47% | $846,461 | 8,890 | -29.8 | $6.4B | Healthcare |
| 23 | Shionogi & Co Ltd | 4507.T | 1.32% | $763,591 | 41,800 | 9.0 | $2.4T | Healthcare |
| 24 | First American Government Obligations Fund 12/01/2031 Swap | FGXXX | 0.37% | $213,269 | 213,269 | — | — | — |
| 25 | Wave Life Sciences Inc | WVE | 0.29% | $165,172 | 44,641 | -3.5 | $745M | Healthcare |
| 26 | Cash & Other Cash | — | 0.17% | $99,027 | 99,027 | — | — | — |
| 27 | SWISS FRANC Private | CHF | -0.45% | $-257,885 | -215,321 | — | — | — |